Market Overview:
The global HPV and PAP testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cervical cancer, rising awareness about HPV and PAP tests, and technological advancements in HPV and PAP testing. The global HPV testing market is segmented by type into primary test types (HPV DNA tests, Hybrid Capture 2 tests) and secondary test types (PCR-based assays, LCR assays). The PCR-based assay segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the increasing demand for molecular diagnostics for early detection of cervical cancer. The global PAP testing market is segmented by application into laboratories, hospitals, clinics, and others.
Product Definition:
HPV is a virus that can cause cervical cancer. PAP testing is a test used to screen for cervical cancer in women. It can detect early signs of the disease before it becomes serious.
HPV Testing:
Human Papillomavirus (HPV) Testing is a laboratory test that helps detect the presence of specific types of HPV. There are more than 100 strains of HPVs, out of which 13 are high risk or cancerous. The other high-risk HPVs include 16 and 18 related to cervical cancer, vulvarcancer, vaginalcancer and oropharyngeal cancer among women and men respectively.
PAP Testing:
Pap test, also known as a Pap test or Papanicolaou testing is used for the detection of abnormal cells in the cervix, which may be precancerous. The test works by detecting cell changes that occur when the body's immune system attacks healthy cells.
Application Insights:
The market is categorized into laboratories, hospitals, clinics and other sites based on application. The others segment includes research institutes, public health facilities and private practices. Hospitals were the largest revenue-generating centers in 2017 owing to the rising prevalence of cancer across the globe. According to WHO, it is estimated that around 1 in 6 women are estimated to develop invasive cervical cancer during their lifetime; however only 1 out of 20 cases are diagnosed due to lack of awareness and under-screening procedures among women population resulting in high demand for diagnostic tests for early diagnosis which will fuel growth over the forecast period.
Laboratories accounted for a significant share as compared with other segments due largely to increasing government funding towards research related towards human papillomavirus (HPV) & PAP testing which has resulted in growing number of laboratories offering these services resulting in high demand from end-users leading toward hospitals & clinics site over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing awareness regarding cancer screening programs, rising prevalence of HPV and PAP-associated diseases, and availability of advanced diagnostic techniques. Moreover, high adoption rate for new technologies in this region is also contributing towards market growth.
Asia Pacific is estimated to be the fastest-growing regional segment over the forecast period owing to growing target population base with increased incidence rate of cervical cancer as a result of high prevalence of human papillomavirus (HPV) types 16 & 18 which cause most cases Cervical Cancer worldwide and low vaccination coverage against HPV infection or lack thereof Gardasil/Gardasek vaccine). In addition, economic development coupled with improvement in healthcare infrastructure will also boost regional growth over the coming years.
Growth Factors:
- Increasing incidence of HPV and cervical cancer: The incidence of HPV and cervical cancer is increasing at a fast pace across the globe. This is primarily owing to the changing lifestyle and growing awareness about the disease. This is expected to drive the demand for HPV and PAP testing in the coming years.
- Growing number of women smokers: Women who smoke are more prone to develop cervical cancer than those who don’t smoke. Hence, there is a growing demand for PAP testing among women smokers across the world.
- Rising prevalence of sexually transmitted diseases (STDs): The prevalence of STDs, such as HIV/AIDS, herpes simplex virus (HSV), human papillomavirus (HPV), etc., has been on a rise in recent years due to changing sexual behavior patterns among people worldwide. This is likely to boost demand for HPV and PAP testing in near future as these tests can help detect early signs of these diseases accurately..
Scope Of The Report
Report Attributes
Report Details
Report Title
HPV and PAP Testing Market Research Report
By Type
HPV Testing, PAP Testing
By Application
Laboratories, Hospitals, Clinics, Others
By Companies
Abbott Laboratories, BD, Danaher Corporation, Seegene, Roche Diagnostics, Arbor Vita Corporation, Hologic, TruScreen, Femasys, Qiagen NV, Oncohealth Corporation, Quest Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
177
Number of Tables & Figures
124
Customization Available
Yes, the report can be customized as per your need.
Global HPV and PAP Testing Market Report Segments:
The global HPV and PAP Testing market is segmented on the basis of:
Types
HPV Testing, PAP Testing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Laboratories, Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- BD
- Danaher Corporation
- Seegene
- Roche Diagnostics
- Arbor Vita Corporation
- Hologic
- TruScreen
- Femasys
- Qiagen NV
- Oncohealth Corporation
- Quest Diagnostics
Highlights of The HPV and PAP Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- HPV Testing
- PAP Testing
- By Application:
- Laboratories
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the HPV and PAP Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
HPV is a virus that can cause cervical cancer. PAP testing is a screening test for cervical cancer that uses an HPV test to help determine if the woman has the virus.
Some of the major players in the hpv and pap testing market are Abbott Laboratories, BD, Danaher Corporation, Seegene, Roche Diagnostics, Arbor Vita Corporation, Hologic, TruScreen, Femasys, Qiagen NV, Oncohealth Corporation, Quest Diagnostics.
The hpv and pap testing market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 HPV and PAP Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 HPV and PAP Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 HPV and PAP Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the HPV and PAP Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global HPV and PAP Testing Market Size & Forecast, 2018-2028
4.5.1 HPV and PAP Testing Market Size and Y-o-Y Growth
4.5.2 HPV and PAP Testing Market Absolute $ Opportunity
Chapter 5 Global HPV and PAP Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 HPV and PAP Testing Market Size Forecast by Type
5.2.1 HPV Testing
5.2.2 PAP Testing
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global HPV and PAP Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 HPV and PAP Testing Market Size Forecast by Applications
6.2.1 Laboratories
6.2.2 Hospitals
6.2.3 Clinics
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global HPV and PAP Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 HPV and PAP Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America HPV and PAP Testing Analysis and Forecast
9.1 Introduction
9.2 North America HPV and PAP Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America HPV and PAP Testing Market Size Forecast by Type
9.6.1 HPV Testing
9.6.2 PAP Testing
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America HPV and PAP Testing Market Size Forecast by Applications
9.10.1 Laboratories
9.10.2 Hospitals
9.10.3 Clinics
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe HPV and PAP Testing Analysis and Forecast
10.1 Introduction
10.2 Europe HPV and PAP Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe HPV and PAP Testing Market Size Forecast by Type
10.6.1 HPV Testing
10.6.2 PAP Testing
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe HPV and PAP Testing Market Size Forecast by Applications
10.10.1 Laboratories
10.10.2 Hospitals
10.10.3 Clinics
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific HPV and PAP Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific HPV and PAP Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific HPV and PAP Testing Market Size Forecast by Type
11.6.1 HPV Testing
11.6.2 PAP Testing
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific HPV and PAP Testing Market Size Forecast by Applications
11.10.1 Laboratories
11.10.2 Hospitals
11.10.3 Clinics
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America HPV and PAP Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America HPV and PAP Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America HPV and PAP Testing Market Size Forecast by Type
12.6.1 HPV Testing
12.6.2 PAP Testing
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America HPV and PAP Testing Market Size Forecast by Applications
12.10.1 Laboratories
12.10.2 Hospitals
12.10.3 Clinics
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) HPV and PAP Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) HPV and PAP Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) HPV and PAP Testing Market Size Forecast by Type
13.6.1 HPV Testing
13.6.2 PAP Testing
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) HPV and PAP Testing Market Size Forecast by Applications
13.10.1 Laboratories
13.10.2 Hospitals
13.10.3 Clinics
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 HPV and PAP Testing Market: Competitive Dashboard
14.2 Global HPV and PAP Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 BD
14.3.3 Danaher Corporation
14.3.4 Seegene
14.3.5 Roche Diagnostics
14.3.6 Arbor Vita Corporation
14.3.7 Hologic
14.3.8 TruScreen
14.3.9 Femasys
14.3.10 Qiagen NV
14.3.11 Oncohealth Corporation
14.3.12 Quest Diagnostics
